HIV-1 Integrase (IN) is the essential viral protein that inserts the viral genome into host DNA, and is a validated antiviral target. Most recently anti-AIDS drugs that target the active site of IN have been developed and are now in clinical use. However, as is often observed with other drug targets, HIV strains that are resistant to these IN inhibitors have emerged, highlighting the constant need to increase our knowledge of this viral protein so that new inhibitors may be designed to add to our arsenal against this deadly virus. This application proposes to study the molecular structure of HIV IN alone and in combination with viral DNA substrates. To perform integration, IN proteins must multimerize in a particular arrangement with viral DNA in the intasome complex. We reason that understanding the molecular details of how the intasome is formed will reveal new vulnerabilities that can be exploited for developing inhibitors. We propose to improve the physical properties of IN for biophysical studies by introducing sequential targeted changes that will promote intasome formation and stability, while maintaining the catalytic activity required for integration. These changes will be combined to optimize intasome formation and, once isolated, intasomes will be subjected to structure determination by both high and low resolution methods. The structural information gained from the experiments described in this application will lay the foundation for the development of a new class of anti-AIDS drugs that target integrase.

Public Health Relevance

The proposed research is focused on determining the structure of the HIV-1 integrase protein which inserts viral DNA into the host cell genome and is essential for virus replication. Detailed structural knowledge of this validated antiviral target cn fuel the discovery of new approaches to fight the ongoing public health threat of HIV/AIDS. This application proposes to elucidate the structural details of the integrase protein-viral DNA complex, to develop new inhibition strategies targeting protein assembly and DNA binding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI118589-01
Application #
8924343
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Sharma, Opendra K
Project Start
2015-04-15
Project End
2017-03-31
Budget Start
2015-04-15
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
$223,125
Indirect Cost
$98,125
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Balasubramanian, Sangeetha; Rajagopalan, Muthukumaran; Bojja, Ravi Shankar et al. (2017) The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study. J Biomol Struct Dyn 35:3469-3485
Andrake, Mark D; Skalka, Anna Marie (2015) Retroviral Integrase: Then and Now. Annu Rev Virol 2:241-64